Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1051
Himax Technologies
HIMX
$2.32B
| $13.5M | 0.01% |
3,263,126
-69,251
| -2% | -$224K |
2018 Q4
6 quarters
|
|
1052
Standard BioTools
LAB
$271M
| $13.5M | 0.01% |
3,366,000
+178,818
| +6% | +$623K |
2015 Q3
19 quarters
|
|
1053
Center Bancorp
CNOB
$1.51B
| $13.5M | 0.01% |
834,856
-100,071
| -11% | -$1.43M |
2013 Q2
28 quarters
|
|
1054
DELISTED
SP Plus Corporation
SP
| $13.5M | 0.01% |
649,700
+11,900
| +2% | +$245K |
2013 Q2
28 quarters
|
|
1055
Flagstar Bank National Association
FLG
$4.7B
| $13.4M | 0.01% |
439,494
-211,958
| -33% | -$6.37M |
2018 Q3
7 quarters
|
|
1056
Sensata Technologies
ST
$6.15B
| $13.4M | 0.01% |
360,800
+35,200
| +11% | +$1.24M |
2018 Q2
8 quarters
|
|
1057
York Water
YORW
$504M
| $13.4M | 0.01% |
279,736
-36,400
| -12% | -$1.58M |
2013 Q2
28 quarters
|
|
1058
Northwest Bancshares
NWBI
$2.15B
| $13.4M | 0.01% |
1,305,868
+473,023
| +57% | +$4.87M |
2013 Q2
28 quarters
|
|
1059
Dover
DOV
$25.4B
| $13.3M | 0.01% |
138,100
-227,700
| -62% | -$21M |
2020 Q1
1 quarter
|
|
1060
Del Monte Corp
DMC
$1.39B
| $13.3M | 0.01% |
541,300
-155,500
| -22% | -$4.07M |
2014 Q3
23 quarters
|
|
1061
Valmont Industries
VMI
$9.03B
| $13.2M | 0.01% |
116,400
+107,300
| +1,179% | +$11.9M |
2020 Q1
1 quarter
|
|
1062
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.91B
| $13.2M | 0.01% |
131,500
+127,081
| +2,876% | +$12.8M |
2020 Q1
1 quarter
|
|
1063
Chesapeake Utilities
CPK
$3.23B
| $13.2M | 0.01% |
157,100
-54,450
| -26% | -$4.73M |
2013 Q2
28 quarters
|
|
|
SWIR
1064
DELISTED
Sierra Wireless
SWIR
| $13.1M | 0.01% |
1,462,100
+10,200
| +0.7% | +$87.1K |
2016 Q3
15 quarters
|
|
|
EIGI
1065
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $13.1M | 0.01% |
3,256,413
-349,280
| -10% | -$1.03M |
2016 Q3
15 quarters
|
|
1066
Home Depot
HD
$290B
| $13.1M | 0.01% |
52,352
+7,780
| +17% | +$1.78M |
2016 Q2
16 quarters
|
|
1067
T. Rowe Price
TROW
$22.4B
| $13M | 0.01% |
105,500
-55,800
| -35% | -$6.36M |
2020 Q1
1 quarter
|
|
1068
Xenon Pharmaceuticals
XENE
$3.53B
| $13M | 0.01% |
1,035,277
+247,200
| +31% | +$3.15M |
2015 Q2
20 quarters
|
|
1069
WisdomTree
WT
$3.43B
| $13M | 0.01% |
3,739,077
-215,702
| -5% | -$655K |
2018 Q3
7 quarters
|
|
1070
DELISTED
First of Long Island Corp
FLIC
| $13M | 0.01% |
793,381
-34,300
| -4% | -$526K |
2013 Q2
28 quarters
|
|
1071
Vanguard Tax-Exempt Bond Index Fund
VTEB
$44.4B
| $13M | 0.01% |
+239,395
| New | +$12.8M |
2020 Q2
0 quarters
|
|
1072
SPDR Gold Trust
GLD
$142B
| $13M | 0.01% |
+77,400
| New | +$12.5M |
2020 Q2
0 quarters
|
|
1073
Carrier Global
CARR
$45.8B
| $13M | 0.01% |
+582,900
| New | +$10.8M |
2020 Q2
0 quarters
|
|
|
XLRN
1074
DELISTED
Acceleron Pharma
XLRN
| $12.9M | 0.01% |
135,600
-64,000
| -32% | -$6.17M |
2020 Q1
1 quarter
|
|
|
LN
1075
DELISTED
LINE Corporation
LN
| $12.9M | 0.01% |
257,755
+97,277
| +61% | +$4.81M |
2018 Q1
9 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.